메뉴 건너뛰기




Volumn 23, Issue 4, 2015, Pages 876-890

Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors

Author keywords

Decahydroisoquinolin; Hydrophobic interaction; Inhibitor; SARS 3CL protease

Indexed keywords

(1,1' BIPHENYL) 4 YL (3 VINYLOCTAHYDROISOQUINOLIN 2(1H) YL)METHANONE; (4 BROMOPHENYL) (3 VINYLOCTAHYDROISOQUINOLIN 2(1H) YL)METHANONE; 2 [(( 2 [(1,1' BIPHENYL) 4 CARBONYL]DECAHYDROISOQUINOLIN 3 YL)METHYL)AMINO] 3 (1H IMIDAZOL 4 YL) N METHOXY N METHYLPROPANAMIDE; 2 [(( 2 [(1,1' BIPHENYL) 4 CARBONYL]DECAHYDROISOQUINOLIN 3 YL)METHYL)AMINO] 3 (1H IMIDAZOL 4 YL)PROPANAL; 2 [(( 2 [(1,1' BIPHENYL) 4 CARBONYL]DECAHYDROISOQUINOLIN 3 YL)METHYL)AMINO] N METHOXY N METHYL 3 (1 TRITYL 1H IMIDAZOL 4 YL)PROPANAMIDE; 2 [(( 2 [(1,1' BIPHENYL) 4 CARBONYL]DECAHYDROISOQUINOLIN 3 YL)METHYL)AMINO] N METHOXY N METHYL 3 (1H IMIDAZOL 4 YL)PROPANAMIDE; 2 [((2 (4 BROMOBENZOYL)DECAHYDROISOQUINOLIN 3 YL)METHYL)AMINO] 3 (1H IMIDAZOL 4 YL) N METHOXY N METHYLPROPANAMIDE; 2 [((2 (4 BROMOBENZOYL)DECAHYDROISOQUINOLIN 3 YL)METHYL)AMINO] 3 (1H IMIDAZOL 4 YL)PROPANAL; 2 [((2 (4 BROMOBENZOYL)DECAHYDROISOQUINOLIN 3 YL)METHYL)AMINO] N METHOXY N METHYL 3 (1 TRITYL 1H IMIDAZOL 4 YL)PROPANAMIDE; 2 [((2 (4 BROMOBENZOYL)DECAHYDROISOQUINOLIN 3 YL)METHYL)AMINO] N METHOXY N METHYL 3 (1H IMIDAZOL 4 YL)PROPANAMIDE; 2 [(6 ((TERT BUTYLDIPHENYLSILYL)OXY)METHYL)CYCLOHEXYL]ETHANOL; 2 [2 (((TERT BUTYLDIPHENYLSILYL)OXY)METHYL)CYCLOHEXYL]ETHANOL; 4 (2 (HYDROXYMETHYL)CYCLOHEXYL)BUT 2 EN 1 YL ACETATE; 4 BROMO N ((2 (4 HYDROXYBUT 2 EN 1 YL)CYCLOHEXYL)METHYL)BENZAMIDE; 4 [2 (((TERT BUTYLDIPHENYLSILYL)OXY)METHY)CYCLOHEXYL]BUT 2 EN 1 OL; 4 [2 (((TERT BUTYLDIPHENYLSILYL)OXY)METHY)CYCLOHEXYL]BUT 2 EN 1 YL ACETATE; 6 (2 ((4 BROMOBENZYL)OXY)ETHYL)CYCLOHEX 3 ENECARBOXYLIC ACID; CHYMOTRYPSIN INHIBITOR; DECAHYDROISOQUINOLIN INHIBITOR; ETHY 4 [2 (((TERT BUTYLDIPHENYLSILYL)OXY)METHY)CYCLOHEX 1 YL]BUT 2 ENOATE; ETHYL 6 (2 (BENZYLOXY)ETHYL)CYCLOHEX 3 ENECARBOXYLATE 7; N [(2 (4 HYDROXYBUT 2 EN 1 YL)CYCLOHEXYL)METHYL] [1,1' BIPHENYL] 4 CARBOXAMIDE; UNCLASSIFIED DRUG; [(6 (2 ((4 BROMOBENZYL)OXY)ETHYL)CYCLOHEX 3 EN 1 YL)METHOXY](TERT BUTYL)DIPHENYLSILANE; [(6 (2 (BENZYLOXY)ETHYL)CYCLOHEX 3 EN 1 YL)METHOXY](TERT BUTYL)DIPHENYLSILANE; [6 (2 ((4 BROMOBENZYL)OXY)ETHYL)CYCLOHEX 3 EN 1 YL]METHANOL; [6 (2 (BENZYLOXY)ETHYL)CYCLOHEX 3 EN 1 YL]METHANOL;

EID: 84964199951     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2014.12.028     Document Type: Article
Times cited : (70)

References (40)
  • 32
    • 84964249225 scopus 로고    scopus 로고
    • Synthesis of (E)-ethyl 5-[(4-bromobenzyl)oxy]pent-2-enoate is included in Supplementary data
    • Synthesis of (E)-ethyl 5-[(4-bromobenzyl)oxy]pent-2-enoate is included in Supplementary data.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.